SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SATT South East SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11246
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SATT South East SAS (SATT South East), formerly Satt Paca Corse SAS, a subsidiary of SATT Association, is a business and consumer services company that offers technology transfer services. The company offers invention disclosure, intellectual property management, economic market, technology consulting and licensing services. It also manages the portfolios of intellectual property of several organizations. The company offers services in areas of digital and connected information society, health and life technologies; environment, energy and territories, industrial processing, and culture, heritage and digital humanities. It serves materials, environment and information technologies such as hardware and embedded, multimedia, data processing, software engineering, chemistry process, material and mechanical engineering, energy, optical, environment and other sectors. SATT South East is headquartered in Marseille, France.

SATT South East SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9
SATT South East SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SATT South East SAS, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
Licensing Agreements 13
SATT Sud Est Enters into Licensing Agreement with Immune Pharma 13
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
SATT Sud Est Enters into Licensing Agreement with Biosantech for HIV Vaccine 15
CleveXel Pharma Enters into Licensing Agreement with Satt Sud Est 16
Raptor Pharma Enters Into Licensing Agreement With Satt Paca Corse For Rett Syndrome 17
SATT South East SAS – Key Competitors 18
SATT South East SAS – Key Employees 19
SATT South East SAS – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
SATT South East SAS, Pharmaceuticals & Healthcare, Key Facts 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9
SATT South East SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Domain Therapeutics Enters into Partnership Agreements with Five SATTs 11
SATT Sud Est Enters into Licensing Agreement with Immune Pharma 13
Imcheck Therapeutics Enters Into Licensing Agreement with Inserm Transfert and SATT South East 14
SATT Sud Est Enters into Licensing Agreement with Biosantech for HIV Vaccine 15
CleveXel Pharma Enters into Licensing Agreement with Satt Sud Est 16
Raptor Pharma Enters Into Licensing Agreement With Satt Paca Corse For Rett Syndrome 17
SATT South East SAS, Key Competitors 18
SATT South East SAS, Key Employees 19

List of Figures
SATT South East SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SATT South East SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SATT South East SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SATT South East SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SATT South East SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sequa Corporation:戦略・SWOT・企業財務分析
    Sequa Corporation - Strategy, SWOT and Corporate Finance Report Summary Sequa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • FUDAN University-製薬・医療分野:企業M&A・提携分析
    Summary FUDAN University (FUDAN) is an educational university that offers bachelor, undergraduate, master and doctoral degrees in various disciplines. The university confers bachelor's degrees in multiple academic disciplines. It conducts research in various disciplines such as natural sciences, dep …
  • SynCore Biotechnology Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary SynCore Biotechnology Co Ltd (SynCore), a subsidiary of Sinphar Pharmaceutical Co Ltd is a biopharmaceutial company that utilizes and in-licenses technologies to develop new drugs. The company’s pipeline products include SB01, SB02, SB03, SB04 and SB05. Its SB01 drug is a new chemical entity …
  • Al Arrab Contracting Company:企業の戦略的SWOT分析
    Al Arrab Contracting Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Compagnie Des Alpes Sa:企業の戦略・SWOT・財務分析
    Compagnie Des Alpes Sa - Strategy, SWOT and Corporate Finance Report Summary Compagnie Des Alpes Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • CellProthera-製薬・医療分野:企業M&A・提携分析
    Summary CellProthera (CellProthera) focuses on the development of therapeutic solutions for the regeneration of organs which are damaged by disease or trauma from autologous blood peripheral stem cells. The company’s lead candidate ProtheraCytes, is an advanced therapy medicinal product within tissu …
  • SURUGA bank Ltd:企業の戦略・SWOT・財務情報
    SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report Summary SURUGA bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tereos:企業の戦略・SWOT・財務分析
    Tereos - Strategy, SWOT and Corporate Finance Report Summary Tereos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • NanoCarrier Co Ltd (4571):企業の財務・戦略的SWOT分析
    Summary NanoCarrier Co Ltd (NanoCarrier) is a drug development company that develops and produces pharmaceuticals using micellar nanoparticles technology. The company’s pipeline products include NC-6004, NC-4016, NC-6300, VB-111, NC-6201 and NK105. It offers siRNA micelle, protein micelle, DACH-plat …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • JSC Gazprom Neft:企業の戦略・SWOT・財務情報
    JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report Summary JSC Gazprom Neft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bourbon SA (GBB):石油・ガス:M&Aディール及び事業提携情報
    Summary Bourbon SA (Bourbon) is a provider of marine and subsea services to the oil and gas industry. The company’s services consist of transport and supply of offshore material, floating production, storage and offloading (FPSO) support, anchor handling, towage and offshore positioning, assistance, …
  • ShawCor Ltd (SCL):企業の財務・戦略的SWOT分析
    ShawCor Ltd (SCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NuStar Energy LP (NS):石油・ガス:M&Aディール及び事業提携情報
    Summary NuStar Energy LP (NuStar Energy) is a midstream oil and gas company. It carries out the transportation, terminalling, storage and marketing of petroleum products, and anhydrous ammonia. The company owns and operates pipelines, terminal and storage facilities that store and distribute crude o …
  • Goodwin Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd is a healthcare company that develops and manufactures vaccines, monoclonal antibodies, recombinant proteins and bioconjugates. The company offers cell culture, purification, bioconjugation, biosimilars, aseptic …
  • Corindus Vascular Robotics Inc (CVRS):企業の財務・戦略的SWOT分析
    Summary Corindus Vascular Robotics Inc (Corindus) is a medical device company that designs, manufactures and commercializes remote robotic systems for interventional surgical procedures. The company offers next-generation CorPath GRX system, a robotic platform that enables improvements in procedural …
  • MediGene AG (MDG1):製薬・医療:M&Aディール及び事業提携情報
    Summary MediGene AG (MediGene) is a biotechnology company which develops drugs for the treatment of various types and stages of cancer with candidates in clinical and pre-clinical development. The company focuses on the development of personalized T-cell-based immunotherapies. Its core business deve …
  • RattanIndia Power Ltd (RTNPOWER):電力:M&Aディール及び事業提携情報
    Summary RattanIndia Power Ltd (RattanIndia Power), formerly Sophia Power Company Ltd is a power company that constructs, develops, operates, and manages thermal power projects across India. The company offers renewable energy solutions, operation and management of power plants, and project managemen …
  • Ontario Power Generation Inc:電力:M&Aディール及び事業提携情報
    Summary Ontario Power Generation Inc (OPG) is an electric utility. It generates and sells energy. The company produces power from nuclear, hydro, and thermal sources. OPG has long-term lease arrangement and related agreements with Bruce Power related to the Bruce nuclear generating stations. It also …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆